| Date Filed | Type | Description |
| 08/23/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/30/2023 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Sold 585 shares
@ $46.76, valued at
$27.4k
|
|
| 06/09/2023 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Ultragenyx Pharmaceutical Inc.|
Txns:
| Granted 3,860 shares
@ $0
Sold 1,485 shares
@ $51.65, valued at
$76.7k
Granted 7,110 options to buy
@ $51.82, valued at
$368.4k
|
|
| 06/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 06/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/21/2021 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 7,800 shares
@ $0
Granted 17,498 options to buy
@ $0 |
|
| 06/04/2021 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $8.98, valued at
$134.7k
|
|
| 08/26/2020 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on BeiGene, Ltd.|
Txns:
| Granted 27,482 options to buy
@ $0 |
|
| 08/26/2020 |
3
| Sanders Corazon (Corsee) D. (Director) has filed a Form 3 on BeiGene, Ltd. |
| 06/01/2020 |
4
| Sanders Corazon (Corsee) D. (Director) has filed a Form 4 on Molecular Templates, Inc.|
Txns:
| Granted 15,000 options to buy
@ $15.43, valued at
$231.5k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |